Isothermal Nucleic Acid Amplification Technology Market 2026
The Isothermal Nucleic Acid Amplification Technology Market was valued at in and is anticipated to reach by , at a CAGR of 0.111 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Isothermal Nucleic Acid Amplification Technology Market.
This report delivers a comprehensive overview of the Isothermal Nucleic Acid Amplification Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology Market. The Isothermal Nucleic Acid Amplification Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Isothermal Nucleic Acid Amplification Technology Market Scope:
By Product Type
This report delivers a comprehensive overview of the Isothermal Nucleic Acid Amplification Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology Market. The Isothermal Nucleic Acid Amplification Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Isothermal Nucleic Acid Amplification Technology Market.
This report delivers a comprehensive overview of the Isothermal Nucleic Acid Amplification Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology Market. The Isothermal Nucleic Acid Amplification Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
Isothermal Nucleic Acid Amplification Technology Market Scope:
By Product Type
- Instruments
- Reagents
- Infectious Diseases Diagnostics
- Blood Screening
- Cancer Research
- Others
- Nucleic Acid Sequence-based Amplification (NASBA)
- Single Primer Isothermal Amplification (SPIA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Helicase-dependent Amplification (HDA)
- Transcription Mediated Amplification (TMA)
- Loop-mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Others
- Hospitals and Clinics
- Diagnostic Center
- Research Laboratories
- Others
- Thermo Fisher Scientific Inc.
- bioMerieux
- Becton, Dickinson & Company
- Lucigen
- Qiagen
- Quidel Corporation
- Eiken Chemical Co. Ltd
- Tecan Genomics Inc.
- Meridian Bioscience
- OptiGene Limited(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Isothermal Nucleic Acid Amplification Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology Market. The Isothermal Nucleic Acid Amplification Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Applications
3.3. Snippet by Technology
3.4. Snippet by End User
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
4.1.1.2. Market Developments
4.1.2. Restraints
4.1.2.1. Growing Trend of Using Refurbished Equipment
4.1.3. Opportunity
4.1.4. Government Initiatives
4.1.5. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. PEST Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. RUSSIA-UKRAINE WAR ANALYSIS
8. GLOBAL RECESSION ANALYSIS
9. ARTIFICIAL INTELLIGENCE IMPACT ANALYSIS
10. BY PRODUCT TYPE
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.1.2. Market Attractiveness Index, By Product Type
10.2. Instruments
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Reagents
11. BY APPLICATIONS
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
11.1.2. Market Attractiveness Index, By Applications
11.2. Infectious Diseases Diagnostics*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Blood Screening
11.4. Cancer Research
11.5. Others
12. BY TECHNOLOGY
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.1.2. Market Attractiveness Index, By Technology
12.2. Nucleic Acid Sequence-based Amplification (NASBA)
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Single Primer Isothermal Amplification (SPIA)
12.4. Nicking Enzyme Amplification Reaction (NEAR)
12.5. Helicase-dependent Amplification (HDA)
12.6. Transcription Mediated Amplification (TMA)
12.7. Loop-mediated Isothermal Amplification (LAMP)
12.8. Strand Displacement Amplification (SDA)
12.9. Others
13. BY END USER
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.1.2. Market Attractiveness Index, By End User
13.2. Hospitals and Clinics
13.2.1. Introduction
13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3. Diagnostic Center
13.4. Research Laboratories
13.5. Others
14. BY REGION
14.1. Introduction
14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key Region-Specific Dynamics
14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.2.7.1. The U.S.
14.2.7.2. Canada
14.2.7.3. Mexico
14.3. Europe
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.3.7.1. Germany
14.3.7.2. The U.K.
14.3.7.3. France
14.3.7.4. Italy
14.3.7.5. Spain
14.3.7.6. Rest of Europe
14.4. South America
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.4.7.1. Brazil
14.4.7.2. Argentina
14.4.7.3. Rest of South America
14.5. Asia-Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.5.7.1. China
14.5.7.2. India
14.5.7.3. Japan
14.5.7.4. Australia
14.5.7.5. Rest of Asia-Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
15. COMPETITIVE LANDSCAPE
15.1. Competitive Scenario
15.2. Market Share Analysis
15.3. Mergers and Acquisitions Analysis
16. COMPANY PROFILES
16.1. Thermo Fisher Scientific Inc.
16.1.1. Company Overview
16.1.2. Product Type Portfolio and Description
16.1.3. Financial Overview
16.1.4. Key Developments
16.2. bioMerieux
16.3. Becton, Dickinson & Company
16.4. Lucigen
16.5. Qiagen
16.6. Quidel Corporation
16.7. Eiken Chemical Co. Ltd
16.8. Tecan Genomics Inc.
16.9. Meridian Bioscience
16.10. OptiGene Limited(*LIST NOT EXHAUSTIVE)
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Applications
3.3. Snippet by Technology
3.4. Snippet by End User
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
4.1.1.2. Market Developments
4.1.2. Restraints
4.1.2.1. Growing Trend of Using Refurbished Equipment
4.1.3. Opportunity
4.1.4. Government Initiatives
4.1.5. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. PEST Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. RUSSIA-UKRAINE WAR ANALYSIS
8. GLOBAL RECESSION ANALYSIS
9. ARTIFICIAL INTELLIGENCE IMPACT ANALYSIS
10. BY PRODUCT TYPE
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.1.2. Market Attractiveness Index, By Product Type
10.2. Instruments
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Reagents
11. BY APPLICATIONS
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
11.1.2. Market Attractiveness Index, By Applications
11.2. Infectious Diseases Diagnostics*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Blood Screening
11.4. Cancer Research
11.5. Others
12. BY TECHNOLOGY
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.1.2. Market Attractiveness Index, By Technology
12.2. Nucleic Acid Sequence-based Amplification (NASBA)
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Single Primer Isothermal Amplification (SPIA)
12.4. Nicking Enzyme Amplification Reaction (NEAR)
12.5. Helicase-dependent Amplification (HDA)
12.6. Transcription Mediated Amplification (TMA)
12.7. Loop-mediated Isothermal Amplification (LAMP)
12.8. Strand Displacement Amplification (SDA)
12.9. Others
13. BY END USER
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.1.2. Market Attractiveness Index, By End User
13.2. Hospitals and Clinics
13.2.1. Introduction
13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3. Diagnostic Center
13.4. Research Laboratories
13.5. Others
14. BY REGION
14.1. Introduction
14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key Region-Specific Dynamics
14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.2.7.1. The U.S.
14.2.7.2. Canada
14.2.7.3. Mexico
14.3. Europe
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.3.7.1. Germany
14.3.7.2. The U.K.
14.3.7.3. France
14.3.7.4. Italy
14.3.7.5. Spain
14.3.7.6. Rest of Europe
14.4. South America
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.4.7.1. Brazil
14.4.7.2. Argentina
14.4.7.3. Rest of South America
14.5. Asia-Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.5.7.1. China
14.5.7.2. India
14.5.7.3. Japan
14.5.7.4. Australia
14.5.7.5. Rest of Asia-Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
15. COMPETITIVE LANDSCAPE
15.1. Competitive Scenario
15.2. Market Share Analysis
15.3. Mergers and Acquisitions Analysis
16. COMPANY PROFILES
16.1. Thermo Fisher Scientific Inc.
16.1.1. Company Overview
16.1.2. Product Type Portfolio and Description
16.1.3. Financial Overview
16.1.4. Key Developments
16.2. bioMerieux
16.3. Becton, Dickinson & Company
16.4. Lucigen
16.5. Qiagen
16.6. Quidel Corporation
16.7. Eiken Chemical Co. Ltd
16.8. Tecan Genomics Inc.
16.9. Meridian Bioscience
16.10. OptiGene Limited(*LIST NOT EXHAUSTIVE)
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
